Home > Income Statement > AJANTA PHARMA

AJANTA PHARMA
Revenue

    Back to Income Statement
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results

AJANTA PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Net Sales ₹3,341 Cr₹2,890 Cr₹2,588 Cr₹2,055 Cr₹2,126 Cr

What is the latest Revenue of AJANTA PHARMA ?

The latest Revenue ratio of AJANTA PHARMA is ₹3,341 Cr based on Mar2023 Consolidated results.
Year Revenue
Mar2023₹3,341 Cr
Mar2022₹2,890 Cr
Mar2021₹2,588 Cr
Mar2020₹2,055 Cr
Mar2019₹2,126 Cr

How is Revenue of AJANTA PHARMA Trending?

Years Revenue % Change
Mar2023 ₹3,341 Cr
15.62
Mar2022 ₹2,890 Cr
11.66
Mar2021 ₹2,588 Cr
25.91
Mar2020 ₹2,055 Cr
-3.31
Mar2019 ₹2,126 Cr -

Compare Revenue of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹27,820.1 Cr 3.5% -0.4% 70.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹365,167.0 Cr 2.6% -4.7% 54.7% Stock Analytics
CIPLA ₹113,645.0 Cr 4.4% -4.4% 54.7% Stock Analytics
DIVIS LABORATORIES ₹105,890.0 Cr 5.8% 17.7% 24.8% Stock Analytics
DR REDDYS LABORATORIES ₹104,987.0 Cr 5.7% 2.7% 29.3% Stock Analytics
ZYDUS LIFESCIENCES ₹96,950.6 Cr 0.4% -5.4% 82.7% Stock Analytics


AJANTA PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

3.5%

-0.4%

70.9%

SENSEX

1.4%

2.5%

24.3%


You may also like the below Video Courses